H. Marchais

发表

Nanovectors for anticancer agents based on superparamagnetic iron oxide nanoparticles

I. Chourpa, C. Linassier, L. Douziech-Eyrolles, 2007, International journal of nanomedicine.

Comparative study of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles prepared by single and double emulsion methods.

I. Chourpa, L. Douziech-Eyrolles, H. Marchais, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Development and characterization of sub-micron poly(D,L-lactide-co-glycolide) particles loaded with magnetite/maghemite nanoparticles.

I. Chourpa, L. Douziech-Eyrolles, H. Marchais, 2005, International journal of pharmaceutics.

siRNA delivery system based on magnetic nanovectors: Characterization and stability evaluation

S. David, I. Chourpa, H. Marchais, 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Intestinal absorption of PLAGA microspheres in the rat.

J. Benoit, M. Aprahamian, M. Pinget, 1996, Journal of anatomy.

Molecular composition of iron oxide nanoparticles, precursors for magnetic drug targeting, as characterized by confocal Raman microspectroscopy.

I. Chourpa, L. Douziech-Eyrolles, H. Marchais, 2005, The Analyst.

Biodegradable microspheres: Advances in production technology

J. Benoit, H. Marchais, H. Rolland, 1996 .

The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications

M. Saboungi, F. Warmont, I. Chourpa, 2008, Nanotechnology.

Optimization of iron oxide nanoparticles encapsulation within poly(d,l-lactide-co-glycolide) sub-micron particles.

I. Chourpa, C. Linassier, L. Douziech-Eyrolles, 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Primidone-loaded poly-ε-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles

C. Chabenat, A. Orecchioni, H. Marchais, 1999 .

Stability assessment of ketoconazole in aqueous formulations.

M. Skiba, P. Arnaud, H. Marchais, 2000, International journal of pharmaceutics.

Formation of gliadin nanoparticles: Influence of the solubility parameter of the protein solvent

A. Orecchioni, H. Marchais, E. Nakache, 1998 .

Stealth magnetic nanocarriers of siRNA as platform for breast cancer theranostics.

S. David, I. Chourpa, H. Marchais, 2017, International journal of pharmaceutics.

Modelling the response surface to predict the hydrodynamic diameters of theranostic magnetic siRNA nanovectors.

S. David, I. Chourpa, H. Marchais, 2015, International journal of pharmaceutics.

Use of experimental design methodology for the development of new magnetic siRNA nanovectors (MSN).

S. David, I. Chourpa, H. Marchais, 2013, International journal of pharmaceutics.

Magnetic nanocarriers for the specific delivery of siRNA: contribution of breast cancer cells active targeting for down-regulation efficiency.

S. David, I. Chourpa, H. Marchais, 2019, International journal of pharmaceutics.

Novel method of doxorubicin-SPION reversible association for magnetic drug targeting.

I. Chourpa, C. Linassier, L. Douziech-Eyrolles, 2008, International journal of pharmaceutics.

Effects of Encapsulation of Primidone on its Oxidative Metabolism in Rats

C. Chabenat, H. Marchais, O. Lafont, 2001, Drug metabolism and drug interactions.

Entrapment efficiency and initial release of phenylbutazone from nanocapsules prepared from different polyesters.

J. Irache, A. Orecchioni, H. Marchais, 1998, Drug development and industrial pharmacy.

Bovine serum albumin release from poly(α-hydroxy acid) microspheres: effects of polymer molecular weight and surface properties

Jean-Pierre Benoit, J. Benoit, H. Marchais, 1997 .

On the interaction of doxorubicin with oleate ions: fluorescence spectroscopy and liquid-liquid extraction study.

I. Chourpa, C. Linassier, L. Douziech-Eyrolles, 2007, Chemical & pharmaceutical bulletin.

Surface characterization of poly(alpha-hydroxy acid) microspheres prepared by a solvent evaporation/extraction process.

J. Benoit, H. Marchais, F. Boury, 1997, Biomaterials.

[Natural immunity to Haemophilus influenzae type b. ELISA study of the distribution of IgG, IgG1 and IgG2 in France and Africa].

H. Marchais, F. Vincent-Ballereau, M. Lafleuriel, 1991, Pathologie-biologie.

Primidone-loaded poly-epsilon-caprolactone nanocapsules: incorporation efficiency and in vitro release profiles.

C. Chabenat, A. Orecchioni, H. Marchais, 1999, International journal of pharmaceutics.

[Sensitivity of Plasmodium falciparum to quinolines and therapeutic strategies: comparison of the situation in Africa and Madagascar between 1983 and 1986].

J. Le bras, I. Hatin, F. Simon, 1987, Bulletin de la Societe de pathologie exotique et de ses filiales.

Cross-linking of hard gelatin carbamazepine capsules: effect of dissolution conditions on in vitro drug release.

M. Skiba, P. Arnaud, J. Legendre, 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[In vivo and in vitro sensitivity to 4-aminoquinolines of Plasmodium falciparum in Madagascar: results of a study conducted on the east coast (July 1985-July 1986)].

J. Le bras, P. Coulanges, H. Marchais, 1987, Archives de l'Institut Pasteur de Madagascar.

[In vivo and in vitro study of the chemosensitivity of Plasmodium falciparum in Madagascar--1982-1986].

J. Le bras, P. Coulanges, J. M. Biaud, 1987, Archives de l'Institut Pasteur de Madagascar.

The development of stable aqueous suspensions of PEGylated SPIONs for biomedical applications

M. Saboungi, I. Chourpa, L. Douziech-Eyrolles, 2008, Nanotechnology.